USFDA completes inspection at Natco Pharma’s API facility in Hyderabad

12 Aug 2019 Evaluate

US Food and Drug Administration (USFDA) has completed inspection at Natco Pharma’s Active Pharmaceutical Ingredient (API) facility in Mekaguda Village, near Hyderabad, India, which was conducted during the period August 05, 2019 to August 09, 2019.

At the end of the inspection, the facility received six observations mostly procedural in nature. The company believes that none of observations are related to data integrity and that all the observations can be addressed within a short period of time.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.

Natco Pharma Share Price

926.20 20.55 (2.27%)
06-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1760.15
Dr. Reddys Lab 1255.95
Cipla 1530.35
Zydus Lifesciences 931.25
Lupin 2151.95
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×